IP Library Granted Patent US 9,878,029
Granted Patent B2
US 9,878,029 · App. 14/006,404 · Granted Jan 30, 2018

Process for preparation of polysaccharides

Inventors: Subhash Kapre (Pune, IN); Swapan Kumar Jana (Pune, IN); Tushar Dnyaneshwar Joglekar (Pune, IN)
Assignee: Serum Institute of India Private Limited
A61K39/092B01D15/327B01D15/361B01D15/362B01D15/363C08B37/0003C12N1/06C12P19/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,878,029
App. No.
14/006,404
Granted
Jan 30, 2018
Kind
B2
Abstract

A novel alcohol and CTAB free process for purification of capsular polysaccharides, wherein the C-polysaccharide, protein, nucleic acid content of the purified polysaccharide is substantially reduced The said process is cost efficient and less laborious.

Claims (25)

1. A cost effective, alcohol- & cetyltrimethylammonium bromide (CTAB)-free chromatography based method for removal of C-polysaccharide from an antigenic polysaccharide which comprises:

(a) lysing bacterial cells in a fermentation medium with deoxycholate thereby producing an aqueous cell lysate containing a polysaccharide solution and solid cell debris;

(b) clarifying the aqueous cell lysate by separating the solid cell debris from the polysaccharide solution;

(c) concentrating the polysaccharide solution by ultrafiltration using a 100 kDa molecular weight cutoff membrane to remove low molecular weight contaminants and to form a solution of concentrated polysaccharide;

(d) treatment of the solution of concentrated polysaccharide with a nuclease;

(e) precipitation of impurities from the solution of concentrated polysaccharide using ammonium sulphate or sodium deoxycholate treatment;

(f) diafiltration of the solution of concentrated polysaccharide using a 100 kDa molecular weight cutoff membrane;

(g) subjecting the solution of concentrated polysaccharide to a multi-step chromatography to produce a purified polysaccharide solution, wherein the multi-step chromatography comprises hydrophobic interaction chromatography (HIC) followed by ion exchange chromatography (IEX);

(h) concentration and diafiltration of the purified polysaccharide solution; and

(i) sterile filtration of the purified polysaccharide solution;

wherein the purified polysaccharide solution shows a 1- to 5-fold reduction of type-specific C-polysaccharide contamination relative to a purified polysaccharide solution obtained by subjecting the solution of concentrated polysaccharide to a single step HIC or ion exchange chromatography; and

wherein the antigenic polysaccharide is a polysaccharide from S. pneumoniae serotype 18C.

2. The method according to claim 1 , wherein the purified polysaccharide solution shows protein contamination less than 1% and nucleic acid contamination less than 1%.

3. The method according to claim 1 , wherein the method requires at least 80% less time and at least 90% less cost than CTAB/Alcohol based methods.

4. The method according to claim 1 , wherein the hydrophobic interaction chromatography support is selected from the group consisting of butyl-agarose, phenyl-agarose, octyl-agarose, phenyl-sepharose and organic polymer resin functionalized with a group selected from butyl, phenyl or ether.

5. The method according to claim 1 , wherein the hydrophobic interaction chromatography column is run in the pH range of 5 to 8.

6. The method according to claim 1 , wherein the hydrophobic interaction chromatography uses a buffer of sodium or potassium phosphate containing 2 M to 5 M sodium chloride salt.

7. The method according to claim 1 , wherein the ion exchange chromatography is an anion exchange chromatography.

8. The method according to claim 7 , wherein the anion exchange chromatography is performed on an anion exchange resin selected from the group consisting of DEAE cellulose, MonoQ, Capto Q, Eshmino Q, Gigacap Q 650M, Nuvia-Q, Cellufine Q-h, MiniQ, Source 15Q and 30Q, Q, DEAE Sepharose Fast Flow, Q Sepharose high Performance, QAE SEPHADEX™ and FAST Q SEPHAROSE™ (GE Healthcare), UNOsphere Q, Macro-Prep DEAE and Macro-Prep High Q from Biorad, Ceramic HyperD Q, ceramic HyperD DEAE, Toyopearl SuperQ-650S, 650M and 650C, QAE-550C and 650S, DEAE-650M.

9. The method according to claim 8 , wherein the anion exchange chromatography is performed on an anion exchange resin Gigacap Q 650M.

10. The method according to claim 7 , wherein the anion exchange column is eluted at 10 to 60% of 1 M NaCl in phosphate buffer.

11. The method according to claim 10 , wherein the anion exchange column is eluted at any one or more of 10%, 15%, 20%, 25%, 30%, 45% and 60% of 1 M NaCl in phosphate buffer.

12. The method according to claim 11 , wherein the anion exchange column is eluted at a linear or step gradient of 1 M NaCl in phosphate buffer.

13. The method according to claim 10 , wherein the anion exchange column is carried out using phosphate buffer ranging from 10 mM to 300 mM.

14. The method according to claim 7 , wherein the anion exchange chromatography is run in the pH range of 5 to 8.

Assignments (2)
CHANGE OF NAME Recorded Dec 7, 2017
From: SERUM INSTITUTE OF INDIA LIMITED
To: SERUM INSTITUTE OF INDIA PRIVATE LIMITED
Reel/Frame 044794/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2017
From: KAPRE, SUBHASH V.; JANA, SWAPAN K.; JOGLEKAR, TUSHAR
To: SERUM INSTITUTE OF INDIA LTD.
Reel/Frame 041076/0871 →
Priority Claims (1)
IN 838/MUM/2011 · Mar 22, 2011 · national
Continuity (1)
Related Publication 20140011265A1 · Jan 9, 2014